Presence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell Transplant
- Status
- TERMINATED
- Phase
- N/A
Clinical Trials Related to Neuroblastoma
Related studies linked through entity extraction aliases.
The Role of Aromatic Hydrocarbon Receptor in the Tumorigenesis of Neuroblastoma and Its Relationship With MYCN Expression
- Status
- COMPLETED
- Phase
- N/A
Safety Study for Refractory or Relapsed Neuroblastoma With DFMO Alone and in Combination With Etoposide
- Status
- COMPLETED
- Phase
- PHASE1
The Role of Glycosyltransferases in the Oncogenesis of Neuroblastoma
- Status
- COMPLETED
- Phase
- N/A
Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features
- Status
- COMPLETED
- Phase
- PHASE1
90Y DOTA/Retinoic Acid for Neuroblastoma and Neuroendocrine Tumor (NET)
- Status
- WITHDRAWN
- Phase
- PHASE2
N2007-03: Vorinostat and 131-I MIBG in Treating Patients With Resistant or Relapsed Neuroblastoma
- Status
- COMPLETED
- Phase
- PHASE1
Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms
- Status
- RECRUITING
- Phase
- N/A
Genomic Structural Variation in Cancer Susceptibility
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Efficacy and Safety of Ultratrace™ Iobenguane I 131 in Neuroblastoma
- Status
- WITHDRAWN
- Phase
- PHASE2
Iodobenzylguanidine Meta-I131 and Topotecan in Young Patients With Refractory or Relapsed Metastatic Neuroblastoma
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Pediatric Participants With Advanced Solid Tumors (P05883, MK-7454-006)
- Status
- TERMINATED
- Phase
- PHASE1
A Phase II Study of Pertuzumab and Erlotinib for Metastatic or Unresectable Neuroendocrine Tumors
- Status
- TERMINATED
- Phase
- PHASE2
Lactobacillus in Preventing Infection in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Myelodysplastic Syndrome
- Status
- TERMINATED
- Phase
- NA
A Vaccine Study for High Risk Cancers
- Status
- WITHDRAWN
- Phase
- PHASE1
Isotretinoin in Treating Young Patients With High-Risk Neuroblastoma
- Status
- UNKNOWN
- Phase
- NA
HSV1716 in Patients With Non-Central Nervous System (Non-CNS) Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Informed Consent in Pediatric Cancer Trials
- Status
- COMPLETED
- Phase
- N/A
Therapy to Treat Ewing's Sarcoma, Rhabdomyosarcoma or Neuroblastoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Studies of Temozolomide in Combination With Topotecan in Refractory and Relapsed Paediatric Solid Tumours
- Status
- COMPLETED
- Phase
- PHASE2